Atara Biotherapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $17,575 | $98,149 | $32,753 | $40,190 |
Gross Profit | 17,021 | 77,710 | 25,958 | 32,588 |
EBITDA | 3,598 | 40,822 | -10,595 | -19,513 |
EBIT | 3,362 | 39,027 | -11,695 | -20,743 |
Net Income | 2,387 | 38,010 | -12,693 | -21,909 |
Net Change In Cash | 17,575 | 98,149 | 32,753 | 40,190 |
Free Cash Flow | -7,318 | -28,138 | -24,561 | -3,989 |
Cash | 16,903 | 13,841 | 25,030 | 46,453 |
Basic Shares | 12,310 | 10,851 | 10,690 | 7,466 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $128,940 | $8,573 | $63,573 | $20,340 |
Gross Profit | 107,931 | -313 | 49,005 | 20,340 |
EBITDA | -75,749 | -265,997 | -213,722 | -331,117 |
EBIT | -80,800 | -270,826 | -228,290 | -340,462 |
Net Income | -85,403 | -276,126 | -2,283,020 | -340,141 |
Net Change In Cash | 128,940 | 8,573 | 63,573 | 20,340 |
Cost of Revenue | -14,390 | -94,320 | ||
Free Cash Flow | -68,963 | -194,200 | -274,623 | -231,102 |
Cash | 25,030 | 25,841 | 92,942 | 106,084 |
Basic Shares | 7,488 | 4,236 | 4,079 | 3,746 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.19 |
2025-03-31 | $3.50 |
2024-12-31 | -$1.19 |
2024-09-30 | -$2.93 |
